North Haven Private Income Fund A LLC 披露未注册份额销售、分配及投资组合数据

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 22, 2026

North Haven Private Income Fund A LLC

(Exact name of Registrant as Specified in Its Charter)

1 (212) 761-4000

(Registrant’s telephone number, including area code)

Not Applicable

(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b- 2 of the Securities Exchange Act of 1934.

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x

Item 3.02. Unregistered Sales of Equity Securities.

As of October 1, 2026, North Haven Private Income Fund A LLC ("we", the "Company" or the "Fund"), sold approximately 42,519 of the Company’s Class I units (the “Units”) for an aggregate offering price of approximately $0.8 million, reflecting a purchase price of $19.57 per unit (with the final number of Units being determined on October 22, 2026).

The sale of Units was made pursuant to subscription agreements entered into by the Company and its unitholders. The issuance of the Units is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) thereof and Regulation D thereunder. The Company relied, in part, upon representations from the unitholders in the subscription agreements that each unitholder was an accredited investor as defined in Regulation D under the Securities Act.

Item 7.01. Regulation FD Disclosure.

On October 26, 2026, the Company disclosed the below information.

Distribution:

On October 22, 2026, the Fund declared a distribution to unitholders of record in the amount of $0.1397 per unit. The distribution will be payable on or around November 4, 2026 to unitholders of record as of October 31, 2026.

Company's Portfolio:

As of September 30, 2026, the Company had investments in 181 portfolio companies across 37 industries with an aggregate par value of approximately $708.1 million, which consisted of approximately 99.7% first lien debt investments and approximately 0.3% other securities, based on par value or, in the case of equity investments, cost. As of September 30, 2026, 99.9% of the debt investments, based on par value, in the Company's portfolio were at floating rates. As of September 30, 2026, approximately 93.8% of the Company’s total investment commitments were in private senior secured loans and equity investments and approximately 6.2% were in broadly syndicated loans, which the Company primarily uses for cash management purposes.

The table below describes investments by industry composition based on par value or, in the case of equity investments, cost as of September 30, 2026:

The table below shows the Company's ten largest portfolio company investments based on par value or, in the case of equity investments, cost as of September 30, 2026:

Net Asset Value:

As of September 30, 2026, the Company's aggregate net asset value ("NAV") is estimated to be approximately $288.7 million. As of September 30, 2026, the Company had approximately $317.1 million of debt outstanding (at principal). Final results may differ materially from the estimated NAV as a result of the completion of the Company’s financial closing procedures, as well as any subsequent events, including the discovery of information affecting fair values of portfolio investments as of September 30, 2026, arising between the date hereof and the completion of the financial statements and the filing of the Company’s quarterly report on Form 10-Q for the period ended September 30, 2026.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.